Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Travere Therapeutics, Inc.

Get SEC filing alerts via email and in your feed for Travere Therapeutics, Inc.

TVTX

Travere Therapeutics, Inc.

Latest news & discussion for Travere Therapeutics, Inc.:

1
1
Travere Therapeutics, Inc. Travere Therapeutics Reports $81.7 Million Revenue in Q1 2025, Significant Loss Reduction

Via official filing (AI summary) | 4 days ago | 0 comments

2
1
Travere Therapeutics, Inc. Travere Therapeutics Reports 60.5% Revenue Growth to $233.2 Million in 2024

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
Travere Therapeutics, Inc. Travere Therapeutics Reports 82% Increase in Net Product Sales, Net Loss Narrows in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments